BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Capitalization
2.01B
38 days until earnings call
OLMA
Price
$4.57
Change
+$0.03 (+0.66%)
Updated
Jul 3 closing price
Capitalization
312.69M
38 days until earnings call
Interact to see
Advertisement

BEAM vs OLMA

Header iconBEAM vs OLMA Comparison
Open Charts BEAM vs OLMABanner chart's image
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$1.36M
Capitalization2.01B
Olema Pharmaceuticals
Price$4.57
Change+$0.03 (+0.66%)
Volume$210.22K
Capitalization312.69M
BEAM vs OLMA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. OLMA commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and OLMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (BEAM: $20.01 vs. OLMA: $4.57)
Brand notoriety: BEAM and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. OLMA: 24%
Market capitalization -- BEAM: $2.01B vs. OLMA: $312.69M
BEAM [@Biotechnology] is valued at $2.01B. OLMA’s [@Biotechnology] market capitalization is $312.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than OLMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while OLMA’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • OLMA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than OLMA.

Price Growth

BEAM (@Biotechnology) experienced а +16.74% price change this week, while OLMA (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

OLMA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than OLMA($313M). BEAM YTD gains are higher at: -19.315 vs. OLMA (-21.612). OLMA has higher annual earnings (EBITDA): -142.36M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. OLMA (393M). OLMA has less debt than BEAM: OLMA (1.15M) vs BEAM (158M). BEAM has higher revenues than OLMA: BEAM (63.6M) vs OLMA (0).
BEAMOLMABEAM / OLMA
Capitalization2.01B313M643%
EBITDA-399.03M-142.36M280%
Gain YTD-19.315-21.61289%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B393M310%
Total Debt158M1.15M13,763%
TECHNICAL ANALYSIS
Technical Analysis
BEAMOLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFGRX53.640.57
+1.07%
Commerce Growth
IMIDX22.670.24
+1.07%
Congress Mid Cap Growth Institutional
INUTX39.950.19
+0.48%
Columbia Dividend Opportunity A
FZAIX56.560.13
+0.23%
Fidelity Advisor International Discv Z
OCHIX8.39-0.01
-0.12%
Oberweis China Opportunities Instl

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.65%
CRSP - BEAM
71%
Closely correlated
+0.97%
NTLA - BEAM
65%
Loosely correlated
+0.09%
RXRX - BEAM
64%
Loosely correlated
+1.15%
ABSI - BEAM
58%
Loosely correlated
+2.97%
PRME - BEAM
58%
Loosely correlated
+1.30%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with ATXS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+0.66%
ATXS - OLMA
47%
Loosely correlated
+1.40%
CRSP - OLMA
46%
Loosely correlated
+0.97%
BEAM - OLMA
46%
Loosely correlated
+0.65%
REPL - OLMA
45%
Loosely correlated
-1.57%
IDYA - OLMA
44%
Loosely correlated
+0.82%
More